Bill Miller's BMY Position Overview
Bill Miller (via Miller Value Partners, LLC) currently holds 69,500 shares of Bristol-Myers Squibb Company (BMY) worth $4.22 M, representing 1.10% of the portfolio. First purchased in 2024-Q1, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Bill Miller has maintained a strategic position in BMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 28,000 shares. Largest reduction occurred in Q1 2026, reducing 38,500 shares.
Analysis based on 13F filings available since 2013 Q2
Bill Miller's Bristol-Myers Squibb Company (BMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bristol-Myers Squibb Company (BMY) Trades by Bill Miller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -38,500 | Reduce 35.65% | 69,500 | $60.65 |
| Q4 2024 | +28,000 | Add 35.00% | 108,000 | $56.56 |
| Q3 2024 | +20,000 | Add 33.33% | 80,000 | $51.74 |
| Q1 2024 | +60,000 | New Buy | 60,000 | $54.23 |
Bill Miller's Bristol-Myers Squibb Company Investment FAQs
Bill Miller first purchased Bristol-Myers Squibb Company (BMY) in Q1 2024, acquiring 60,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Bill Miller has held Bristol-Myers Squibb Company (BMY) for 9 quarters since Q1 2024.
Bill Miller's largest addition to Bristol-Myers Squibb Company (BMY) was in Q1 2024, adding 60,000 shares worth $3.25 M.
According to the latest 13F filing for Q1 2026, Bill Miller's firm, Miller Value Partners, LLC, owns 69,500 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $4.22 M.
As of the Q1 2026 filing, Bristol-Myers Squibb Company (BMY) represents approximately 1.10% of Bill Miller's publicly disclosed stock portfolio, making it one of their key holdings.
Bill Miller's peak holding in Bristol-Myers Squibb Company (BMY) was 108,000 shares, as reported at the end of Q4 2024.